Huberman breaks down the biology of major depression and the science-backed tools, drugs, and diets that can treat it.

Andrew Huberman: Professor of Neurobiology and Ophthalmology at Stanford School of Medicine and host of the Huberman Lab Podcast. This is a solo episode with no outside guest.
In this solo episode, Andrew Huberman delivers a deep dive into major (unipolar) depression, covering its symptomology, underlying neurochemistry, and evidence-based treatments. He explains the roles of norepinephrine, dopamine, and serotonin, plus the contributions of stress, cortisol, thyroid hormone, genetics, and inflammation. He then maps science-backed tools to those mechanisms: EPA omega-3s, exercise, creatine, fermented foods, and ketogenic diet. Finally he surveys cutting-edge clinical therapies including ketamine, PCP, and psilocybin, emphasizing neuroplasticity and the role of layer five of the cortex.
Eli Lilly
“some of those drugs include things like Prozac or Zoloft, the more typical names or more generic names are things like fluoxetine”— Andrew Huberman
Pfizer
“some of those drugs include things like Prozac or Zoloft, the more typical names or more generic names are things like fluoxetine”— Andrew Huberman
GlaxoSmithKline
“There are drugs like Wellbutrin, which function more specifically on the dopamine system to increase dopamine and they also increase norepinephrine.”— Andrew Huberman
Johnson & Johnson
“There's actually some data showing that pain relievers, Tylenol, Aspirin, these sorts of things, can help certain people with emotional pain.”— Andrew Huberman
Pfizer
“the benzodiazepines and things of the Xanax, variety, Valium, and so forth. Those increased GABA transmission.”— Andrew Huberman
Roche
“the benzodiazepines and things of the Xanax, variety, Valium, and so forth. Those increased GABA transmission.”— Andrew Huberman